Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Soliton Inc

(NASDAQ: SOLY)
Add to Portfolio
-0.14 (-1.07%)
as of 20:00 EST

Last 12.91
Change -0.14 (-1.07%)
Open 13.20
Prev. Close 13.05
Today's Range
12.89
13.25
52wk Range
4.12
29.00
Volume 132,100
Avg Volume 195,700
Sector SIC-3841 Surgical & Medical Instruments & Apparatus

Perfomance Comparison

Name Today 3-Month 1-Year
SOLY -1.07% +15.17% +165.09%
DJIA +0.40% +6.03% +13.35%
S&P 500 +0.47% +8.62% +21.81%

Key Statistics

Annual EPS N/A
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 213,350
Weighted Alpha +13.50
Standard Deviation -0.27
Profit Margin N/A
Beta N/A

Growth Rates

YTD +17.58%
1-Year +182.47%

Opinion

Sell Hold Buy

Recent Headlines

Global Medical Device Industry Bolstering Outstanding

PR Newswire via COMTEX - Tue Feb 11, 08:45AM EST
There is no doubt that the global medical device market has been showing outstanding growth for the last few years and that it will continue to do so in the near future... and most likely beyond then. It also should see the North (full story)
SOLY: 12.91 (-0.14), MDT: 113.77 (+1.11), IVC: 8.93 (+0.21), RMTI: 2.95 (+0.05), ABT: 89.36 (+0.48)

Soliton Files Special 510(k) with FDA for its

PR Newswire via COMTEX - Tue Feb 11, 08:00AM EST
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 12.91 (-0.14)

Soliton Advances Market Launch Preparation; Appoints

PR Newswire via COMTEX - Thu Feb 06, 08:00AM EST
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 12.91 (-0.14)

Soliton Announces Positive Data from Extended Keloid

PR Newswire via COMTEX - Mon Jan 27, 08:00AM EST
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 12.91 (-0.14)

Soliton To Announce Keloid and Hypertrophic Scar

PR Newswire via COMTEX - Mon Jan 13, 08:00AM EST
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson")(full story)
SOLY: 12.91 (-0.14)